Antitrust Review
Government review of M&A transactions for anticompetitive effects — conducted by the FTC and DOJ under Hart-Scott-Rodino filing requirements for deals above statutory thresholds. Most SMB deals don't trigger formal antitrust review; transactions in concentrated industries or by large serial acquirers face closer scrutiny. See [HSR Act](#hsr-act-hart-scott-rodino) for full treatment.
Full Definition
Antitrust review is a regulatory process through which government agencies evaluate whether a proposed merger or acquisition would harm competition — and either approve, conditionally approve (with required divestitures or behavioral remedies), or block the transaction. In the United States, the primary antitrust regulators are the Department of Justice (DOJ) Antitrust Division and the Federal Trade Commission (FTC). International deals may trigger parallel reviews in the EU, UK, Canada, and other jurisdictions.
HSR filing thresholds: The Hart-Scott-Rodino Antitrust Improvements Act requires parties to certain transactions to file pre-merger notifications with the DOJ and FTC and observe a waiting period before closing. As of 2024, the basic size-of-transaction threshold is approximately $119.5M (adjusted annually for inflation). Below this threshold — which covers virtually all SMB acquisitions — no HSR filing is required, and antitrust review is not a formal closing condition. The parties can close without government notification.
When antitrust matters in SMB M&A: SMB deals rarely trigger HSR requirements, but antitrust analysis is still relevant in two situations: (1) when a strategic acquirer with significant market share in a concentrated local market acquires a direct competitor — even if the dollar threshold isn't met, the DOJ and FTC can investigate transactions post-close if they harm competition; and (2) when the deal is a component of a larger acquisition strategy that could face regulatory scrutiny in aggregate.
Remedies and timelines: When a filing is required, the agencies have 30 days to review (15 days for cash tender offers). They may issue a "Second Request" — a detailed information demand that effectively pauses the deal clock and can take 6–12 months to resolve. Remedies can include divesting specific business units or committing to behavioral restrictions (pricing, access, interoperability).
Seller vs. Buyer Perspective
For the vast majority of SMB sellers, antitrust review is not a meaningful closing risk. If your buyer is a large strategic acquirer who is already a significant player in your market, ask whether they've assessed HSR filing requirements and antitrust risk — not to delay the deal, but to ensure the buyer isn't carrying an undisclosed regulatory risk that could prevent closing. In competitive acquisitions, a buyer with antitrust exposure should carry a higher reverse breakup fee to compensate you for the risk of a regulatory block.
Before signing any acquisition agreement, confirm whether an HSR filing is required and whether the transaction raises substantive antitrust concerns even absent a filing requirement. A transaction that closes but faces post-close investigation is costly and disruptive. If you are a serial acquirer in a specific market, track your cumulative market share — the agencies increasingly scrutinize "roll-up" strategies even when individual deals fall below filing thresholds. Factor regulatory risk into your deal certainty analysis and insure against it in your reverse breakup fee provisions.
Real-World Example
A large regional grocery chain acquires a smaller independent grocer in its primary market — $8M deal, well below HSR thresholds. Two years later, the FTC's small merger enforcement unit investigates whether the acquisition reduced grocery competition in a rural county. The investigation costs the acquirer $400K in legal fees and results in a consent decree requiring the chain to offer lower prices in specific product categories for three years.
Why It Matters & Common Pitfalls
- !Below-threshold doesn't mean zero risk. The DOJ and FTC have authority to challenge transactions at any size if they harm competition. In concentrated local markets — healthcare, fuel distribution, funeral services, broadband — even small deals can attract scrutiny.
- !International deals multiply complexity. Any acquisition involving meaningful revenue in the EU, UK, or Canada may require separate filings with different thresholds, timelines, and substantive standards. Build international regulatory analysis into the deal timeline early.
- !Second Requests are deal killers without planning. A Second Request from the DOJ or FTC can extend the closing timeline by 6–12 months and cost millions in legal and document review costs. Deals with antitrust risk need a contractual framework (outside date, regulatory efforts covenant, reverse breakup fee) that accounts for this possibility.
- !Behavioral remedies linger post-close. Antitrust consent decrees can obligate the combined company to specific conduct for 5–10 years. Factor ongoing compliance costs into your post-close operating model if regulatory remedies are a realistic outcome.
Frequently Asked Questions
What triggers antitrust review in M&A?↓
Can antitrust review block a deal?↓
Related Terms
Hart-Scott-Rodino (HSR) Act
A federal law requiring advance notification to the FTC and DOJ for M&A transactions above certain size thresholds — triggering a mandatory waiting period for antitrust review before closing.
Closing Conditions
Closing conditions are requirements that must be met before a deal can close — regulatory approvals, rep accuracy, no material adverse change. Failure to satisfy can delay or kill deals.
Merger
A transaction in which two companies combine into one legal entity by operation of law — rather than one buying assets or stock of the other — with shareholders of both receiving stock or cash in the surviving entity.
Get Weekly M&A Insights
Valuation data, deal analysis, and plain-English M&A education — every week.
The LegacyVector Newsletter
Join 5,000+ business owners, investors, and buyers who get weekly M&A market data and deal insights.
- Weekly valuation multiples by industry
- SBA lending rates & deal financing data
- Market trends & acquisition opportunities
No spam. Unsubscribe anytime. Free forever.
Disclaimer: The information provided on this page is for educational and informational purposes only. It should not be considered financial, legal, or investment advice. Business valuations depend on many factors specific to each situation. Always consult with qualified professionals — including business brokers, CPAs, and M&A attorneys — before making acquisition or sale decisions. LegacyVector is not a licensed broker, financial advisor, or attorney. Data shown may be based on limited samples and may not reflect current market conditions.
LegacyVector Research Team
Reviewed by M&A professionals · Updated April 2026